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The interest to the problem of nonalcoholic fatty liver disease has been growing in the world. There is no standard 
treatment regimen of nonalcoholic steatohepatitis (NASH), as well as insufficient dosage recommendations for the management of 
patients with NASH, based on the large randomized controlled trials.  
Objective: to improve the diagnosis and treatment efficiency of NASH based on the study of pathogenetic mechanisms of 
the disease. 
Matherials and methods: We observed 65pathients: 32 patients with NASH who received basic therapy 
(ursodesoxycholic acid, 10 mg/kg/day). 33 patients with NASH who received in addition to basic therapy thiotriasolin 2 ml of 
2.5% solution intramuscularly 2 times per day during 5 days, followed by 100 mg (tablet) 3 times per day during 20 days. The 
control group contains 20 healthy persons without fatty liver infiltration according to ultrasound. The diagnosis of NASH based 
on a comprehensive analysis of complaints data, physical examination, results of laboratory and instrumental studies. The 
presence of NASH confirmed by ultrasound and increased activity of serum transaminases not more than 5 norms. Patients in 
these groups were representative for age and gender. Patients were conducted in dynamics. Symptoms were assessed at admission 
and after 25 days of therapy. Statistical processing of the results was performed according to the method of variation statistics. 
Results: In 49.2% of patients with NASH clinical manifestations were not found. The main complaints of patients were 
heaviness in the right hypochondrium, feeling of bittertaste in the mouth, feeling of heaviness after eating fatty and fried foods and 
asthenic manifestations. Increased liver in size was observed in 78.8% of patients with NASH. There were increased levels of 
CRP in patients with NASH in accordance with the control group (p<0.05), confirming that these patients had chronic subclinical 
inflammation. The presence of a positive correlation between CRP and ALT levels (r= 0,63; p <0,001). Clinical manifestations of 
NASH and transaminase levels did not differ significantly as a result of treatment, both in the application of basic therapy, and in 
the combination with thiotriasoline. Application of Thiotriazoline, unlike basic treatment, led to the decrease of CRP to that of the 
control group. 
Conclusion: The use of Thiotriazoline in combination with the basic treatment causes a marked reduction of CRP levels in 
patients with NASH. That enhances the antiinflammatory efficacy of thiotriasoline with basic treatment in patients with NASH, 
helping to slow the progression of the disease. 
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